Cargando…
Human iPSC-derived mesoangioblasts, like their tissue-derived counterparts, suppress T cell proliferation through IDO- and PGE-2-dependent pathways
Human mesoangioblasts are currently in a phase I/II clinical trial for the treatment of patients with Duchenne muscular dystrophy. However, limitations associated with the finite life span of these cells combined with the significant numbers of mesoangioblasts required to treat all of the skeletal m...
Autores principales: | Li, Ou, English, Karen, Tonlorenzi, Rossana, Cossu, Giulio, Saverio Tedesco, Francesco, Wood, Kathryn J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968899/ https://www.ncbi.nlm.nih.gov/pubmed/24715949 http://dx.doi.org/10.12688/f1000research.2-24.v1 |
Ejemplares similares
-
PW1/Peg3 expression regulates key properties that determine mesoangioblast stem cell competence
por: Bonfanti, Chiara, et al.
Publicado: (2015) -
Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation
por: Palumbo, Roberta, et al.
Publicado: (2004) -
Globular Adiponectin as a Complete Mesoangioblast Regulator: Role in Proliferation, Survival, Motility, and Skeletal Muscle Differentiation
por: Fiaschi, Tania, et al.
Publicado: (2010) -
Optimised generation of iPSC-derived macrophages and dendritic cells that are functionally and transcriptionally similar to their primary counterparts
por: Monkley, Susan, et al.
Publicado: (2020) -
Intra‐arterial transplantation of HLA‐matched donor mesoangioblasts in Duchenne muscular dystrophy
por: Cossu, Giulio, et al.
Publicado: (2015)